Cargando…
Enhancement of tumor tropism of mPEGylated nanoparticles by anti-mPEG bispecific antibody for ovarian cancer therapy
Ovarian cancer is highly metastatic, with a high frequency of relapse, and is the most fatal gynecologic malignancy in women worldwide. It is important to elevate the drug susceptibility and cytotoxicity of ovarian cancer cells, thereby eliminating resident cancer cells for more effective therapeuti...
Autores principales: | Lin, Wen-Wei, Cheng, Yi-An, Li, Chia-Ching, Ho, Kai-Wen, Chen, Huei-Jen, Chen, I.-J.u, Huang, Bo-Cheng, Liu, Hui-Ju, Lu, Yun-Chi, Cheng, Chiu-Min, Huang, Ming-Yii, Lai, Hung-Wen, Cheng, Tian-Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027450/ https://www.ncbi.nlm.nih.gov/pubmed/33828191 http://dx.doi.org/10.1038/s41598-021-87271-2 |
Ejemplares similares
-
Bispecific antibodies (anti-mPEG/anti-HER2) for active tumor targeting of docetaxel (DTX)-loaded mPEGylated nanocarriers to enhance the chemotherapeutic efficacy of HER2-overexpressing tumors
por: Su, Chia-Yu, et al.
Publicado: (2018) -
Double attack strategy for leukemia using a pre-targeting bispecific antibody (CD20 Ab-mPEG scFv) and actively attracting PEGylated liposomal doxorubicin to enhance anti-tumor activity
por: Ho, Kai-Wen, et al.
Publicado: (2021) -
Humanized bispecific antibody (mPEG × HER2) rapidly confers PEGylated nanoparticles tumor specificity for multimodality imaging in breast cancer
por: Cheng, Yi-An, et al.
Publicado: (2020) -
Functionalization of silver nanoparticles with mPEGylated luteolin for selective visual detection of Hg(2+) in water sample
por: Qing, Weixia, et al.
Publicado: (2018) -
Combined Docetaxel/Pictilisib-Loaded mPEGylated Nanocarriers with Dual HER2 Targeting Antibodies for Synergistic Chemotherapy of Breast Cancer
por: Cheng, Wei-Jie, et al.
Publicado: (2022)